Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

$200M per year in Rexista rev's alone...making all 7 of IPCI's pending FDA ANDA approvals just extra gravy for the real coming meat on their best in class NDA's choo-choo;)

I've been saying that for 2-1/2 years now... it was never about the generics... yes they are a sweetner, but it's always been about Rexista and Regabatin... although Regabatin won't happen until end of 2018 when the pregabalin molecule goes off patent.

And... again... 20K shares now makes you a millionaire in 3 to 5 years.